Arizona Patent of the Month – July 2024
StimAire Inc. has secured a patent for their proprietary neuromodulation system which represents a groundbreaking advancement in the field of non-invasive medical treatments. This innovative device utilizes a free running resonance magnetic field generator to modulate neural activity, offering a new approach to managing various neurological conditions.
At the heart of the system is a housing that contains a coil and a capacitor connected in parallel, creating a resonance that delivers precise stimulation signals. The generator is powered by a DC supply and controlled by a sophisticated switch mechanism involving a microprocessor, transistor, and rectifier, which finely tunes the timing of magnetic pulses to maximize therapeutic effects while minimizing power consumption.
One of the key features of StimAire’s system is its flexibility and adaptability. The magnetic field generator can be attached to the body using an adhesive, ensuring that it remains securely in place during treatment. The inclusion of a rechargeable battery and a contact sensor that conserves energy when not in use enhances the device’s practicality and ease of use. Additionally, the system can accommodate both flexible and rigid coils, with the flexible coils made from durable materials like BoPET and PTFE, ensuring comfort and longevity. This adaptability allows the device to be used in various therapeutic contexts, from targeting specific neurons in the brain to managing pain in peripheral nerves.
StimAire’s neuromodulation system stands out for its ability to provide continuous, targeted stimulation without overheating—a common issue with previous magnetic stimulators. By recycling the inductive energy of the coil and using low-voltage power supplies, the system maintains effective stimulation over longer periods, significantly improving treatment outcomes. This capability, combined with its compact and wearable design, positions StimAire’s invention as a leading solution for enhancing neural function and providing relief from neurological disorders.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
